Zai Lab registers Phase 3 trial for ZL-1310 in lung cancer and real-world KarXT study in ChinaSep 3Weekly roundup, 2 itemsxanomeline and trospium chlorideZai Lab (Shanghai) Co., Ltd.
Boehringer Ingelheim registers Phase Ib/II trial pairing obrixtamig with Zai Lab's ZL-1310 in SCLCJul 16Trial updateBoehringer IngelheimZai Lab (Shanghai) Co., Ltd.
Sign inSign in